UNSPSC 85601512: Supplement ileocecal valve with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement ileocecal valve with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DUC47Z

UNSPSC 85601512 Supplement ileocecal valve with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that nominally describes a surgical implant procedure, but the recent state and local opportunities tagged under it involve occupational and disability medical evaluation services, pharmacy benefit administration, and temporary health professional staffing—none of which align with the code's surgical scope. The City of Phoenix Retirement Office (September 2026 RFP for disability medical record summary and independent medical examinations), Washington State Department of Transportation (August 2026 RFP for occupational medical surveillance across ferry system locations), Collier County (August 2026 RFP for pharmacy benefit management), and the County of Santa Clara Health System (July 2026 RFQ for temporary ancillary health professional staffing) are among recent issuing bodies. The mismatch between the code's nominal scope and the work actually being solicited suggests this code is receiving inconsistent or incorrect tagging at the point of posting and does not currently serve as a reliable signal for procurement activity in surgical implant procedures.

The geographic spread of the recent opportunities spans Arizona (Phoenix), Washington State, Florida (Collier County), and California (Santa Clara County), with an additional Harris County, Texas information request. Because the opportunities do not reflect the code's stated surgical-procedure scope, pursuing activity under this code without independent verification of the issuer's actual commodity need carries significant risk of misalignment. Contractors in surgical implant supply, interventional procedures, or related medical device sectors should not rely on this code for market intelligence without direct confirmation from the issuing body about its intended application.